FDA Grants Orphan Drug Designation to Gene Therapy Treatment for Angelman Syndrome
1_Agilis_logo3_HR-2

Agilis Biotherapeutics and Dr. Edwin Weeber take giant step forward toward a functional cure for Angelman Syndrome.  For Further information, read the press release here.

X
X